about
Impact of high risk drug use on hospitalization and mortality in older people with and without Alzheimer's disease: a national population cohort studyAssessing medication burden and polypharmacy: finding the perfect measureThinking through the medication list - appropriate prescribing and deprescribing in robust and frail older patients.Mild cognitive impairment predicts institutionalization among older men: a population-based cohort studyMultiple, but not traditional risk factors predict mortality in older people: the Concord Health and Ageing in Men Project.High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population levelGentamicin pharmacokinetics in old age and frailtyPolypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.Manual versus automated coding of free-text self-reported medication data in the 45 and Up Study: a validation study.How fast does the Grim Reaper walk? Receiver operating characteristics curve analysis in healthy men aged 70 and over.De-adoption and its 43 related terms: harmonizing low-value care terminology.A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland.Statin use and clinical outcomes in older men: a prospective population-based study.Drug Burden Index and physical function in older Australian men.Pharmacoepidemiology in the postmarketing assessment of the safety and efficacy of drugs in older adults.Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes.Clinical implications from drug-drug and drug-disease interactions in older people.A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people.Reducing inappropriate polypharmacy: the process of deprescribing.Prescription and administration of opioids to hospital in-patients, and barriers to effective use.Health Care Practitioners' Perspectives on Deprescribing Anticholinergic and Sedative Medications in Older Adults.A pilot randomized clinical trial utilizing the drug burden index to reduce exposure to anticholinergic and sedative medications in older people.Association Rules Analysis of Comorbidity and Multimorbidity: The Concord Health and Aging in Men Project.Prevalence of Potential and Clinically Relevant Statin-Drug Interactions in Frail and Robust Older Inpatients.Anticholinergic burden in older women: not seeing the wood for the trees?Assessing the harms of polypharmacy requires careful interpretation and consistent definitions.Muscle strength and sedative load in community-dwelling people aged 75 years and older: a population-based study.Age and opioid analgesia in an acute hospital population.Emergency hospitalizations for adverse drug events.Associations between drug burden index and mortality in older people in residential aged care facilities.Drug Burden Index and hospitalization among community-dwelling older people.Prevalence and impact of fall-risk-increasing drugs, polypharmacy, and drug-drug interactions in robust versus frail hospitalised falls patients: a prospective cohort study.Drug burden index and beers criteria: impact on functional outcomes in older people living in self-care retirement villages.Rethinking psychotropics in nursing homes.Prescribing for frail older people.Understanding drug effects in older people: the role of pharmacology.Optimal cutoff of polypharmacy and outcomes - reply.Modifications to the drug burden index calculation may limit interpretation of its association with clinical outcomes in older adults.Ascertainment of self-reported prescription medication use compared with pharmaceutical claims data.Prevalence of Potentially Inappropriate Medication Use in Older Inpatients with and without Cognitive Impairment: A Systematic Review.
P50
Q28538635-B36440A4-F3D5-4C8C-91E7-A7A586831E32Q33814172-8F1B01B2-F9A5-4534-B397-F7DCD37355BBQ34315480-8B3544D4-7CEA-4E71-8EDC-4100F98C3255Q34430750-731AFBBF-5E2F-4673-BBA6-4BE1D5A72EACQ34527530-B5B57EB4-0A9E-4ADC-A96D-AF537A714C04Q34578984-BBD291C3-9DCA-443F-9BFC-5AE3D6ED8D3FQ34580596-49CD5C9C-15A4-448F-AC0A-0AADE795D713Q34639755-4E88F897-6DDF-45FB-B9E7-9B1C9A75BBE3Q35596057-67E5E33A-D5DC-4F2F-B34B-2C412F43F171Q35618840-69C289DA-8EC5-4178-9984-E176BA6A360BQ35815256-3829E636-6ABD-4512-8042-4A6E51DDE1A2Q36206447-57F43BF4-5438-46D6-AB88-9CBF05A3026FQ36730168-E96E883E-8281-4E7B-B1BD-25F6E4852412Q37321432-2D17256A-35CD-4EFB-833A-60DE568E36DFQ37886484-EC6D9A25-C237-41B5-9B5D-8FBBDEB2FB5BQ38002442-4CE7932D-AA10-4D62-B2F5-B529E3C1DCC8Q38092903-B71DE5EA-76AB-49A3-93B8-A270A8B4E856Q38812617-45D68877-2D22-4136-83CC-E5326F5B7494Q39026437-0CBAA1BA-BC9F-4E63-B7CF-D88A1993B3FFQ39295471-5176CCC1-1363-4581-8399-EEAE7DF62459Q39712942-7188CB10-599E-4992-B095-AB35631AF1B7Q39833325-40D42140-FB9D-45F4-AA4D-A9A142805ED5Q40385601-54CB1FB5-D940-45A2-B91D-D1DBD5ABA54FQ40459838-65465467-BEC9-48AF-9408-F44D15D84848Q41517306-E1FCBB00-EEE2-4E2D-B655-4B1AC33C1E13Q43033187-0A67855C-1587-4110-85B0-66E68617AEDBQ43483947-80862C1B-1601-4361-B068-42AE31B40122Q44339709-9CC34E6D-4F80-4429-BF6D-98BDFB95A524Q44482348-1681FB14-6911-45BC-AA8A-EEDA28DBCAB3Q44670916-A583E031-5B65-4F63-8E1A-43BB07E3D9AFQ44799043-07164D3B-5039-4830-8F46-E83EABA3E4E4Q44959362-1CF41B64-1D8C-40DF-93B6-882956273F6BQ44975215-ABF09E64-1FEE-44AC-A3E8-F9FFB78514E2Q45353451-2F1D1208-9E27-4650-9BD2-29B6D0B6F401Q46085200-3B0B670A-D107-4942-A888-E11D2F2C263AQ46543609-8AF97B06-90C1-497C-8F12-3926636861F5Q46653346-D7D48A17-2B90-4A03-BA30-E06DF8CB7750Q46933469-9069B3AD-A00E-44C7-9F75-B62AC3841E98Q47636029-BCE30A90-4DD8-4421-9F2B-5E8D3B36A67CQ47763564-00DCAA72-5C95-49C4-BBA0-DF5682FB746F
P50
name
Danijela Gnjidic
@ast
Danijela Gnjidic
@en
Danijela Gnjidic
@nl
type
label
Danijela Gnjidic
@ast
Danijela Gnjidic
@en
Danijela Gnjidic
@nl
prefLabel
Danijela Gnjidic
@ast
Danijela Gnjidic
@en
Danijela Gnjidic
@nl